findmyKOL

Norman Magid, MD

Basic profile

Cornell University

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2017findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2017Online presenceNot yet checkedPaymentsNone reportedNIH funding1988–1992Why? →

Norman Magid is a Cardiology physician affiliated with Cornell University. OpenAlex indexes 37 publications with 1,421 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
37publications

Distinct works indexed by OpenAlex.

1,421citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1988–1992

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

45 E End Ave
Suite 1s
New York, NY 100287953

Telephone

212-752-3464

Registry record last updated 29 May 2014.

View the NPPES registry record

Medicare prescribing footprint (2021)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    74.6%
    Statin21.8%
    Atorvastatin Calcium53%Simvastatin31%Rosuvastatin Calcium16%
    Part D50 patients
    Beta blocker18.3%
    Metoprolol Succinate73%Atenolol27%
    Part D51 patients

    + 8 more classes in this area

  • Blood & clotting

    12.8%
    Factor Xa inhibitor5.5%
    Eliquis100%
    Part D16 patients
    P2Y12 inhibitor4.1%
    Clopidogrel53%Brilinta47%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    7.7%
    Proton pump inhibitor4%
    Omeprazole100%
    Part D13 patients
    H2 blocker3.7%
    Famotidine100%
    Part D13 patients
Where care is delivered (Part B), 20207.2% facility · 92.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19881992 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”